Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.265
-0.965 (-43.27%)
At close: Aug 1, 2025, 4:00 PM
1.270
+0.005 (0.40%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Catalent Market Cap
Zynex has a market cap or net worth of $38.25 million as of August 1, 2025. Its market cap has decreased by -88.32% in one year.
Market Cap
38.25M
Enterprise Value
93.17M
1-Year Change
-88.32%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since February 12, 2019, Zynex's market cap has decreased from $154.40M to $38.25M, a decrease of -75.23%. That is a compound annual growth rate of -19.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 38.20M | -85.03% |
| Dec 31, 2024 | 255.10M | -30.90% |
| Dec 29, 2023 | 369.20M | -29.14% |
| Dec 30, 2022 | 521.00M | 50.23% |
| Dec 31, 2021 | 346.80M | -25.83% |
| Dec 31, 2020 | 467.60M | 81.45% |
| Dec 31, 2019 | 257.70M | 66.90% |
| Feb 12, 2019 | 154.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |